PMGC Holdings Inc. SEC filings ELAB

PMGC Holdings Inc. has 273 filings in SEC EDGAR's recent list, going back to Oct 1, 2021. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement). The company's fiscal year ends on December 31.

PMGC Holdings Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 22, 2026 —
4 Insider transaction Oct 22, 2026 Oct 20, 2026
SCHEDULE 13D Ownership over 5% (active) Sep 29, 2026 —
4 Insider transaction Jun 3, 2026 Jun 1, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 3, 2026 —
SCHEDULE 13D Ownership over 5% (active) Jun 3, 2026 —
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
3/A Filing Feb 10, 2026 Nov 13, 2023
3/A Filing Feb 9, 2026 Nov 13, 2023
3 Initial insider ownership Jan 29, 2026 Mar 6, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 3, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 16, 2025 —
4 Insider transaction Mar 28, 2025 Mar 26, 2025
SCHEDULE 13D Ownership over 5% (active) Mar 28, 2025 —
3/A Filing Mar 28, 2025 Nov 13, 2023
4 Insider transaction Mar 28, 2025 Mar 26, 2025
SCHEDULE 13D Ownership over 5% (active) Mar 28, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 28, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Mar 24, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 31, 2025 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Oct 2, 2024 —
SC 13G Ownership over 5% (passive) Oct 1, 2024 —
SC 13G Ownership over 5% (passive) Sep 26, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Aug 16, 2024 —
SC 13G Ownership over 5% (passive) May 31, 2024 —
SC 13D Ownership over 5% (active) Feb 21, 2024 —
3/A Filing Feb 16, 2024 Nov 13, 2023
3/A Filing Feb 16, 2024 Dec 28, 2023
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
3 Initial insider ownership Feb 1, 2024 Dec 28, 2023
4 Insider transaction Feb 1, 2024 Dec 28, 2023
3/A Filing Feb 1, 2024 Nov 13, 2023
3 Initial insider ownership Jan 25, 2024 Nov 13, 2023
3 Initial insider ownership Jan 18, 2024 Nov 13, 2023
3 Initial insider ownership Jan 18, 2024 Nov 13, 2023
3 Initial insider ownership Jan 18, 2024 Nov 13, 2023
3 Initial insider ownership Jan 18, 2024 Nov 13, 2023
3 Initial insider ownership Jan 17, 2024 Nov 13, 2023
3 Initial insider ownership Jan 17, 2024 Nov 13, 2023
3 Initial insider ownership Jan 17, 2024 Nov 13, 2023
3 Initial insider ownership Jan 17, 2024 Nov 13, 2023
3 Initial insider ownership Jan 17, 2024 Nov 13, 2023
3 Initial insider ownership Jan 17, 2024 Nov 13, 2023
3 Initial insider ownership Jan 17, 2024 Nov 13, 2023

Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ELAB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Newport Beach, CA
SEC filer status
, Emerging growth company
SEC CIK
1840563
Former names
Elevai Labs Inc. (until Nov 27, 2024); Reactive Medical Labs Inc. (until Oct 14, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.